Ocular Comfort Clinical Trial
Official title:
Evaluation of Comfort in Symptomatic Contact Lens Wearers
Verified date | November 2021 |
Source | Alcon Research |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study is to evaluate the comfort of an ocular lubricant in symptomatic contact lens wearers. This study will be conducted in Canada.
Status | Completed |
Enrollment | 17 |
Est. completion date | October 29, 2021 |
Est. primary completion date | October 29, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Key Inclusion Criteria: - Is able to understand and sign an approved information consent letter; - Habitually wears daily disposable soft contact lenses in both eyes; - Is able to achieve 20/40 or better monocular VA with habitual contact lenses; - Has a pair of spectacles for vision correction. - Other protocol-defined inclusion criteria may apply. Key Exclusion Criteria: - Routinely sleeps in habitual contact lenses; - Has any known active ocular disease and/or infection; - Is pregnant or lactating; - Other protocol-defined exclusion criteria may apply. |
Country | Name | City | State |
---|---|---|---|
Canada | Alcon Investigative Site 6189 | Waterloo | Ontario |
Lead Sponsor | Collaborator |
---|---|
Alcon Research |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Comfort, collected for each eye | A visual analogue scale will be used | Up to Day 6 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04693429 -
Clinical Study for the Evaluation of Safety and Tolerability of PRO-172 Ophthalmic Solution+
|
Phase 1 | |
Completed |
NCT01423773 -
Ocular Comfort and OCT Observation of Post Lens Clearance and Ocular Tissue Compression
|
N/A | |
Completed |
NCT00520260 -
Bromfenac 0.09% vs Ketorolac 0.4% for Cyclosporine Induction Phase
|
Phase 4 |